Development of a Cancer Pain Assessment Tool in Korea: A Validation Study of a Korean Version of the Brief Pain Inventory

Yun, Young Ho; Mendoza, Tito R.; Heo, Dae Seog; Yoo, Taiwoo; Heo, Bong Yul; Park, Hyeoun Ae; Shin, Ho Cheol; Wang, Xin Shelley; Cleeland, Charles S.

doi:10.1159/000079497

Cited by 126 publications

(121 citation statements)

References 11 publications

(27 reference statements)

Supporting

Mentioning

105

Contrasting

Unclassified

Order By: Relevance

“…The Korean version of the BPI was recently introduced and validated in 2004. 12 In the 2006 survey, we generated questionnaires similar to the Korean BPI. However, in 2001, we had just started to pay attention to cancer pain, and thus the questionnaire was not fully prepared.…”

Section: Discussionmentioning

confidence: 99%

“…11 The Korean Cancer Pain Assessment Tool, developed in 2003, is accepted as a reliable and valid instrument for assessing cancer pain in Korea. 12 The Korean government first published Cancer Pain Management Guidelines for Health Care Professionals in 2004. 13 Five years after distribution of the first pain management guideline document to Korean physicians, KSHPC constructed a baseline database to improve the outcome of cancer pain management and to evaluate 1) differences in the prevalence and intensity of cancer pain between 2001 and 2006; 2) patient attitudes and the degree of satisfaction with pain management; and 3) differences in the pain management index (PMI) to assess the adequacy of pain control between 2001 and 2006.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Change in Cancer Pain Management in Korea Between 2001 and 2006: Results of Two Nationwide Surveys

Hong

Roh

Kim

et al. 2011

Journal of Pain and Symptom Management

View full text Add to dashboard Cite

Context. In Korea, many health care professionals have shown increased concern about the management of cancer pain. Five years after a pain management guideline was distributed to Korean physicians, the Korean Society of Hospice and Palliative Care evaluated the change in cancer pain management. The period evaluated was between 2001 and 2006.Methods. We did a prospective, cross-sectional cancer pain survey on the change of the pain prevalence and pain intensity, its impact on daily activities and the adequacy of pain management between 2001 and 2006.Results. Overall, 7565 patients were enrolled from 72 cancer hospitals in the 2001 cancer pain survey and 7245 patients were enrolled from 63 cancer hospitals in the 2006 cancer pain survey. The overall prevalence of cancer pain and the percentage of patients reporting a negative pain management index were significantly decreased in the 2006 cancer pain survey compared with the 2001 cancer pain survey (44.9% vs. 52.1%, P < 0.0001 and 41.6% vs. 45.0%, respectively, P ¼ 0.0005). However, in 2006, physicians did not prescribe analgesics to 25.8% of the patients with severe pain and they did not adjust the prescribed analgesics properly in 47.4% of the patients with severe pain.Conclusion. Some improvement in cancer pain management was noted during the five years between 2001 and 2006. However, all of the physicians who care for

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Change in Cancer Pain Management in Korea Between 2001 and 2006: Results of Two Nationwide Surveys

Hong

Roh

Kim

et al. 2011

Journal of Pain and Symptom Management

View full text Add to dashboard Cite

show abstract

“…The BPI uses a 10-point scale whereby 0 ϭ "no pain" and 10 ϭ "pain as bad as you can imagine" to evaluate intensity of pain (11). The BPI has shown its validity across cultural and linguistic backgrounds (12)(13)(14)(15) as well as diverse clinical situations (16 -19), including dialysis patients (1,20). On the basis of the BPI scale, pain was classified as mild (1 to 4 points), moderate (5 to 6 points), or severe (7 to 10 points) (20).…”

Section: Methodsmentioning

confidence: 99%

Calcium, Parathyroid Hormone, and Vitamin D

Golan¹,

Haggiag²,

Os³

et al. 2009

Clinical Journal of the American Society of Nephrology

View full text Add to dashboard Cite

Background and objectives: Pain is a frequent complaint of hemodialysis (HD) patients, yet information regarding its causes and frequency is relatively scarce. The aim of this study was to evaluate the frequency and possible causes of chronic pain in patients who are on long-term HD.Design, setting, participants, & measurements: We prospectively enrolled 100 patients who were undergoing maintenance HD for at least 3 mo. Pain was evaluated using the Brief Pain Inventory. Data collected on each participant included age, gender, ethnic origin, body mass index, smoking habits, time on dialysis, type of blood access, comorbidities, and biochemical and hematologic parameters.Results: The average age was 64.5 yr; the average time on dialysis 40.4 mo. Forty-five patients were male. Thirty-one participants were of Arabic origin. Fifty-three patients had diabetes, 36 of whom had diabetic retinopathy. Although 51 patients experienced chronic pain, only 19.6% described the pain as severe. Musculoskeletal pain, neuropathic pain, and headache were the most prevalent forms of pain. The presence of diabetic retinopathy and neuropathy (but not diabetes per se) and levels of intact parathyroid hormone, calcium, and calcitriol (but not 25-hydroxyvitamin D 3 ) differed significantly between those who experienced chronic pain and those who did not. On a logistic regression model, higher serum calcium levels and intact parathyroid hormone levels >250 pg/ml were independently associated with chronic pain, as well as the presence of diabetic retinopathy. Calcitriol had a marginal effect.Conclusions: Disturbed mineral metabolism is strongly associated with chronic pain in long-term HD patients, along with microangiopathy.

show abstract

“…La versión corta del BPI se adaptó para varios países, por ejemplo, Portugal (6,7), Alemania (8), Tailandia (9,10), Grecia (11), España (12), Italia (13), Noruega (14,15), Estados Unidos (16,17), Corea (18), Canadá (19), Rusia (20), Líbano (21) y Brasil (22). La escala se adaptó con mayor frecuencia para su uso en personas con dolor de origen oncológico (9)(10)(11)(12)14,17,18,(20)(21)(22) y, posteriormente, en personas con las siguientes patologías: dolor crónico no maligno (13,16), dolor crónico músculo-esquelético (6,7), osteoartritis (15), estrés postraumático (19) y sida (17).…”

Section: Introductionunclassified

“…La escala se adaptó con mayor frecuencia para su uso en personas con dolor de origen oncológico (9)(10)(11)(12)14,17,18,(20)(21)(22) y, posteriormente, en personas con las siguientes patologías: dolor crónico no maligno (13,16), dolor crónico músculo-esquelético (6,7), osteoartritis (15), estrés postraumático (19) y sida (17). El tamaño de las muestras utilizadas en los diferentes estudios varió entre 75 (21) y 520 (10) personas con dolor.…”

Section: Introductionunclassified

Validación del Brief Pain Inventory en personas con enfermedad renal crónica

Sousa¹,

Marques-Vieira²,

Severino³

et al. 2017

Aquichan

View full text Add to dashboard Cite

RESUMENObjetivo: comprobar las propiedades psicométricas de la versión portuguesa del Brief Pain Inventory, en personas con enfermedad renal crónica sometidas a hemodiálisis. Método: estudio metodológico. La muestra seleccionada está compuesta por 171 personas con enfermedad renal crónica que presentan dolor durante al menos 24 horas y realizan hemodiálisis en dos clínicas de la región de Lisboa, Portugal. Los datos se recogieron entre mayo y junio del 2015. Se evaluaron las siguientes propiedades psicométricas: validez (constructo, convergente y discriminante), confiabilidad (α de Cronbach) y estabilidad (test-retest). Resultados: se obtuvo información que apoya adecuadamente una estructura bifactorial (interferencia del dolor y grado de severidad del dolor), con confiabilidad (α = 0,90 y α = 0,80, respectivamente) y estabilidad. Las medidas registradas están correlacionadas de forma positiva con el afecto negativo, y de forma negativa, con las medidas de calidad de vida, que sustentan la validez concurrente. Se comprobó la existencia de apoyo para la validez predictiva. Conclusiones: las medidas del "grado de severidad del dolor" e "interferencia del dolor" que se obtuvieron a través del Brief Pain Inventory son válidas y reproducibles en personas con enfermedad renal crónica que presentaron dolor en las últimas 24 horas, cuando se utiliza el cuestionario y la entrevista. PALABRAS CLAVEInsuficiencia renal crónica; diálisis renal; dimensión del dolor; estudios de validación; psicometría (Fuente: DeCS, BIREME). Method: This is a methodological study. The selected sample is comprised of 171 persons with chronic kidney disease who experience pain for at least 24 hours and are undergoing hemodialysis at two clinics in Lisbon, Portugal. The data were collected between May and June 2015. The psychometric properties that were evaluated include validity (construct, convergent and discriminant), reliability (Cronbach's α) and stability (test-retest). Results: Information was obtained that adequately supports a bi-factor structure (pain interference and degree of pain severity), with reliability (α = 0.90 and α = 0.80, respectively) and stability. The measures registered correlate positively with the negative effect, and negatively, with measures of quality of life, which support concurrent validity. The existence of support for predictive validity was verified. Conclusions: The "pain severity" and "pain interference" measures obtained with the Brief Pain Inventory are valid and reproducible in persons with chronic kidney disease who experienced pain during the 24 hours before the questionnaire was used and the interview was conducted.

show abstract

Development of a Cancer Pain Assessment Tool in Korea: A Validation Study of a Korean Version of the Brief Pain Inventory

Cited by 126 publications

References 11 publications

Change in Cancer Pain Management in Korea Between 2001 and 2006: Results of Two Nationwide Surveys

Change in Cancer Pain Management in Korea Between 2001 and 2006: Results of Two Nationwide Surveys

Calcium, Parathyroid Hormone, and Vitamin D

Validación del Brief Pain Inventory en personas con enfermedad renal crónica

Contact Info

Product

Resources

About